Aurion Biotech Expands Leadership Team, Promoting Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)-- #Biotech--Aurion Biotech, a clinical-stage regenerative medicine company with a mission to restore vision to millions of patients, today announced the promotions of Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer. These strategic appointments were made as the company prepares to initiate a U.S. Phase 3 clinical trial in the first quarter of 2026. Aurion Biotech is developing AURN001, an